Enzyme Induction
ASSESSING MODELING AND SIMULATION TOOLS AND METHODS FOR PREDICTING INDUCTION-BASED DRUG-DRUG INTERACTIONS: A COLLABORATIVE EFFORT BETWEEN ACADEMIC, GOVERNMENT REGULATORY, AND PHARMACEUTICAL SCIENTISTS FROM THE IQ CONSORTIUM (IQC)
Heidi Einolf, Novartis Institutes for BioMedical Research Inc.;
Liangfu Chen, GlaxoSmithKline;
Odette A. Fahmi, Pfizer;
Christopher R. Gibson, Merck Research Laboratories;
R. Scott Obach, Pfizer Global Research & Development;
Mohamad Shebley, Abbott Laboratories;
Michael Sinz, Bristol-Myers Squibb Co;
Jose Silva, Johnson & Johnson Pharmaceutical Research and Development, LLC.;
Jashvant D. Unadkat, University of Washington;
Lei Zhang, U.S. Food and Drug Administration;
Ping Zhao, CDER, FDA
![[ Visit Client Website ]](images/banner.gif)